Technology area: Biotechnology & Pharmaceuticals
13 pending office actions • 13 art units • 13 examiners • 0 of 13 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Monash University has 13 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 13 examiners and 13 art units, so each pending matter has its own recorded examination assignment.
RAILEY, JENNIFER A is the busiest examiner, with 1 pending matter. Portfolio management should emphasize systematic tracking and preserve matter-specific analysis across the biotechnology docket.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (15%) |
| Double-patenting only | 1 (8%) |
| Double-patenting + other | 1 (8%) |
| Multi-statute (no §101) | 9 (69%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAILEY, JENNIFER A | 1 | 79.6% | +7.9% |
| DIETZ, NOE ROBERT | 1 | 0.0% | +0.0% |
| VU, VU A | 1 | 92.3% | +6.7% |
| DAUNER, JOSEPH G | 1 | 57.0% | +35.3% |
| WERTZ, ASHLEE ELIZABETH | 1 | 52.7% | +35.6% |
| AZPURU, CARLOS A | 1 | 83.8% | +10.8% |
| XIE, XIAOZHEN | 1 | 56.7% | +65.7% |
| BYRD, BRIGID K | 1 | 71.4% | +46.4% |
| FETTEROLF, BRANDON J | 1 | 51.6% | +18.5% |
| TAYLOR, LIA ELAN | 1 | 64.2% | +29.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18707515 | NEGATIVE CAPACITANCE TOPOLOGICAL QUANTUM FIELD-EFFECT TRANSISTOR | VU, VU A | — |
| 18409546 | LIPID PRODRUGS OF NEUROSTEROIDS | AZPURU, CARLOS A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17772107 | TREATMENT OF RENAL CYSTIC DISEASE | HUDSON, AMY ROSE | 5d |
| 17771982 | ANTIBODIES FOR BINDING PLASMINOGEN | TAYLOR, LIA ELAN | 15d |
| 18723351 | ROBOTIC FRUIT HARVESTING SYSTEM AND METHOD | RAILEY, JENNIFER A | — |
| 18719203 | METHOD AND APPARATUS FOR PROMOTING MOTILITY OF FLAGELLAR CELLS | DIETZ, NOE ROBERT | — |
| 18291808 | LIPID NANOPARTICLE FORMULATIONS | WERTZ, ASHLEE ELIZABETH | — |
| 18273156 | FUSION PROTEINS | XIE, XIAOZHEN | — |
| 17792042 | COMPOSITIONS AND METHODS | FETTEROLF, BRANDON J | — |
| 17626168 | METHODS FOR MAKING RECOMBINANT PROTEIN | REGLAS, GEORGIANA C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18314951 | SURGICAL SYSTEM AND METHOD OF USE | BYRD, BRIGID K | 42d overdue |
| 17771982 | ANTIBODIES FOR BINDING PLASMINOGEN | TAYLOR, LIA ELAN | 15d |
| 18698074 | METHOD OF DETERMINING A TARGET POLYMER IN A SAMPLE BY USING A GUIDE POLYMER | DAUNER, JOSEPH G | — |
| 18291808 | LIPID NANOPARTICLE FORMULATIONS | WERTZ, ASHLEE ELIZABETH | — |
| 18409546 | LIPID PRODRUGS OF NEUROSTEROIDS | AZPURU, CARLOS A | — |
| 18273156 | FUSION PROTEINS | XIE, XIAOZHEN | — |
| 17792042 | COMPOSITIONS AND METHODS | FETTEROLF, BRANDON J | — |
| Art Unit | Apps |
|---|---|
| 3676 | 1 |
| 3791 | 1 |
| 2897 | 1 |
| 1682 | 1 |
| 1612 | 1 |
| 1617 | 1 |
| 1674 | 1 |
| 3771 | 1 |
| 1626 | 1 |
| 1641 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18723351 | ROBOTIC FRUIT HARVESTING SYSTEM AND METHOD | RAILEY, JENNIFER A | 3676 | §102§103 | Final Rejection | — | Pending | Jun 21, 2024 |
| 18719203 | METHOD AND APPARATUS FOR PROMOTING MOTILITY OF FLAGELLAR CELLS | DIETZ, NOE ROBERT | 3791 | §103§112 | Non-Final OA | — | Pending | Jun 12, 2024 |
| 18707515 | NEGATIVE CAPACITANCE TOPOLOGICAL QUANTUM FIELD-EFFECT TRANSISTOR | VU, VU A | 2897 | §103 | Non-Final OA | — | Pending | May 03, 2024 |
| 18698074 | METHOD OF DETERMINING A TARGET POLYMER IN A SAMPLE BY USING A GUIDE POLYMER | DAUNER, JOSEPH G | 1682 | §102§112DP | Non-Final OA | — | Pending | Apr 03, 2024 |
| 18291808 | LIPID NANOPARTICLE FORMULATIONS | WERTZ, ASHLEE ELIZABETH | 1612 | §102§103§112 | Non-Final OA | — | Pending | Jan 24, 2024 |
| 18409546 | LIPID PRODRUGS OF NEUROSTEROIDS | AZPURU, CARLOS A | 1617 | DP | Non-Final OA | — | Pending | Jan 10, 2024 |
| 18273156 | FUSION PROTEINS | XIE, XIAOZHEN | 1674 | §102§103§112 | Non-Final OA | — | Pending | Jul 19, 2023 |
| 18314951 | SURGICAL SYSTEM AND METHOD OF USE | BYRD, BRIGID K | 3771 | §103 | Non-Final OA | 42d overdue | Pending | May 10, 2023 |
| 17792042 | COMPOSITIONS AND METHODS | FETTEROLF, BRANDON J | 1626 | §102§103 | Non-Final OA | — | Pending | Jul 11, 2022 |
| 17771982 | ANTIBODIES FOR BINDING PLASMINOGEN | TAYLOR, LIA ELAN | 1641 | §102§103 | Final Rejection | 15d | Pending | Apr 26, 2022 |
| 17772107 | TREATMENT OF RENAL CYSTIC DISEASE | HUDSON, AMY ROSE | 1636 | §103§112 | Non-Final OA | 5d | Pending | Apr 26, 2022 |
| 17626168 | METHODS FOR MAKING RECOMBINANT PROTEIN | REGLAS, GEORGIANA C | 1651 | §103§112 | Final Rejection | — | Pending | Jan 11, 2022 |
| 17598380 | A MICROPARTICLE AND/OR NANOPARTICLE SEPARATION, FILTRATION AND/OR ENRICHING DEVICE AND METHOD | BULLOCK, IN SUK C | 1772 | §102§103 | Non-Final OA | — | Pending | Sep 27, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMonash University has 13 pending office actions as of October 2026, spread across 13 art units and 13 examiners.
Jennifer A Railey has the most, with 1 of Monash University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
